Platelet activation during carotid endarterectomy and the antiplatelet effect of dextran 40

Platelets

Volumn 13, Issue 4, 2002, Pages 231-239

  Robless, P A ^a   Tegos, T J ^b   Okonko, D ^a   Mansfield, A O ^a   Nicolaides, A N ^b   Mikhailidis, D P ^c   Stansby, G ^d  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN 40; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DEXTRAN; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOEMBOLISM; BLOOD; BLOOD CLOTTING PARAMETERS; BRAIN EMBOLISM; DRUG SCREENING; ECHOGRAPHY; MIDDLE AGED;

AGED; ANTICOAGULANTS; DEXTRANS; DRUG EVALUATION; ENDARTERECTOMY, CAROTID; FEMALE; FLOW CYTOMETRY; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; THROMBOEMBOLISM; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0036074604     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100220144849     Document Type: Article

References (66)

1. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST)
2. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
3. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis
4. Endarterectomy for Asymptomatic Carotid Artery Stenosis
5. Platelet kinetics following carotid endarterectomy: The effect of aspirin and patch angioplasty
6. Platelet activation in flowing blood passing growing arterial thrombi
7. Thrombin generation in patients undergoing carotid endarterectomy: Implications in acute vessel wall closure and antithrombotic therapy
8. Pathophysiology of platelet thrombin receptors
9. Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease
10. Transcranial Doppler microembolus detection in the identification of patients at high risk of perioperative stroke
11. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy
12. Interpretation of Embolic Phenomena During Carotid Endarterectomy
13. Reducing the risk of carotid surgery: A 7-year audit of the role of monitoring and quality control assessment
14. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia
15. Aspirin dose in stroke prevention: Beautiful hypothesis slain by ugly facts
16. Platelets of patients with peripheral arterial disease are hypersensitive to heparin
17. Pathophysiology of heparin induced thrombocytopenia (HIT)
18. Prevention of postoperative thrombotic stroke after carotid endarterectomy: The role of transcranial Doppler ultrasound
19. Selective shunting using transcranial Doppler, Near infrared spectroscopy and stump pressure measurements during carotid endarterectomy
20. Correlates of embolic events detected by means of transcranial Doppler in patients with carotid atheroma
21. Consensus on microembolus detection by TCD
22. Transcranial Doppler directed Dextran therapy in the prevention of post-operative carotid artery thrombosis: 3 hrs monitoring is as effective as 6 hrs
23. Factors that contribute to spontaneous platelet aggregation and streptokinase induced aggregation in whole blood
24. Naftidrofuryl and Aspirin on platelet aggregation in peripheral vascular disease
25. Diminished platelet yield and enhanced platelet aggregability in platelet rich plasma of peripheral vascular disease patients
26. The effect of cooling on in vitro vascular prostacyclin and platelet thromboxane A2 synthesis: Relevance to cold-induced pathology
27. The use of flow cytometry to study platelet activation
28. Detection of activated platelets in whole blood using activation dependant monoclonal antibodies and whole blood flow cytometry
29. Postoperative thromboembolism and its prevention with 500 ml dextran given during operation. With a special study of the venous flow pattern in the lower extremity
30. The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass
31. Prevention of postoperative thrombotic stroke after carotid endarterectomy: The role of transcranial Doppler ultrasound
32. Dextran and haemostasis - A review
33. Effect of dextran on factor VIII (antihemophilic factor) and platelet function
34. The clinical importance of acquired abnormalities of platelet function
35. Human neutrophil cathepsin G is a potent platelet activator
36. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality
37. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
38. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
39. A systematic review of antiplatelet therapy for prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease
40. Low dose aspirin fails to inhibit increased platelet reactivity in patients with peripheral vascular disease
41. Ticlopidine and Clopidogrel
42. Platelet GPIIb-IIIa blockers
43. Is clopidogrel markedly superior to aspirin in patients with peripheral vascular disease?
44. Differential effects of anticoagulants on the activation of platelets ex vivo
45. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation
46. Changes in platelet membrane glycoprotein IIb-IIIa complex during platelet activation
47. A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation
48. PADGEM (GMP-140) is a component of the Weibel Palade bodies of human endothelial cells
49. GMP-140 mediates adhesion of stimulated platelets to neutrophils
50. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
51. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
52. Evaluation of platelet membrane glycoproteins in coronary artery disease
53. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate or an in vivo wound
54. Bidirectional trafficking of membrane glycoproteins following platelet activation in suspension
55. Mechanisms initiating platelet thrombus formation
56. The pathogenesis of coronary artery disease and the acute coronary artery syndromes: Part 1
57. Mechanisms leading to myocardial infarction: Insights fom studies of vascular biology. Lewis A. Connor Memorial Lecture
58. Platelet deposition at carotid endarterectomy sites in humans
59. Inadequate cerebral perfusion is an unlikely cause of peri-operative stroke
60. Vessel wall and indium 111 labelled platelet response to carotid endarterectomy
61. Dextran prophylaxis of venous thromboembolism
62. Dextran in prophylaxis of thrombosis in fracture of the hip
63. The effect of low molecular weight dextran on early platelet deposition onto vascular grafts
64. Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography
65. Clinical relevance of intraoperative embolisation detected by transcranial ultrasonography during carotid endarterectomy: A prospective study of 100 patients
66. Does dextran 40 improve the early patency of autogenous infrainguinal bypass grafts?